HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY
Technology
E-065-2017
Patent ID
E-065-2017-0-US-06
Country
US
Application Type
National Stage
Patent Status
Issued
Patent Number
11389480
Publication Number
US-2020-0230173
Application Number
16/614,652
IC
NCI
Date Filed
Date Issued